Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin in COVID-19 Pneumonia (AziA)
NCT04363060Phase 3Unknown
- Sponsor
- CHU de Nantes
- Start
- Apr 2020
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azithromycin in COVID-19 pneumonia, sponsored by CHU de Nantes. Status: unknown.
02
Drugs
azithromycin
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04363060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04363060.